Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants.
Allaw F, Haddad SF, Zakhour J, Kanj SS.
Int J Antimicrob Agents. 2023 Aug;62(2):106860. doi: 10.1016/j.ijantimicag.2023.106860. Epub 2023 May 21.
PMID:37220849
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T, Velázquez GF, Schmid C.
Mol Cancer. 2023 Nov 11;22(1):180. doi: 10.1186/s12943-023-01889-6.
PMID:37951964
Historical Perspective of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Aslam MF, Cheema AY, Shahid D, Maryam B, Mukhopadhyay D, Munir M, Najam A, Ali HM, Bashir Q, Anwer F.
Acta Haematol. 2025;148(3):315-329. doi: 10.1159/000542704. Epub 2024 Nov 25.
PMID:39586285
T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation.
Gaudeaux P, Moirangthem RD, Bauquet A, Simons L, Joshi A, Cavazzana M, Nègre O, Soheili S, André I.
Front Immunol. 2022 Jul 7;13:956919. doi: 10.3389/fimmu.2022.956919. eCollection 2022.
PMID:35874778
Central nervous system complications after allogeneic hematopoietic stem cell transplantation.
Chaudhary RK, Dhakal P, Aryal A, Bhatt VR.
Future Oncol. 2017 Oct;13(25):2297-2312. doi: 10.2217/fon-2017-0274. Epub 2017 Oct 6.
PMID:28984145
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update.
Wang Y, Chang YJ, Chen J, Han M, Hu J, Hu J, Huang H, Lai Y, Liu D, Liu Q, Luo Y, Jiang EL, Jiang M, Song Y, Tang XW, Wu D, Xia LH, Xu K, Zhang X, Zhang XH, Huang X.
Cancer Lett. 2024 Nov 28;605:217264. doi: 10.1016/j.canlet.2024.217264. Epub 2024 Sep 25.
PMID:39332587
Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.
Lv M, Huang XJ.
J Hematol Oncol. 2012 Mar 18;5:10. doi: 10.1186/1756-8722-5-10.